The global demand for Hemodialysis & Peritoneal Dialysis Market is presumed to reach the market size of nearly USD 199.87 BN by 2030 from USD 95.3 BN in 2022 with a CAGR of 9.7% under the study period 2023 - 2030.
Hemodialysis and peritoneal dialysis are two different methods used to treat individuals with kidney failure, also known as end-stage renal disease (ESRD). Both of these methods serve the vital purpose of eliminating waste products along with excess fluids from the body when the kidneys are no longer capable of performing this function effectively.
Market Dynamics
The Hemodialysis and peritoneal dialysis market is experiencing significant growth due to a confluence of factors that underscore the rising prevalence of end-stage renal disease (ESRD) and the need for advanced renal replacement therapies. One of the primary drivers is the increasing incidence of chronic kidney disease (CKD) and ESRD, linked to factors like aging populations, diabetes, hypertension, and lifestyle-related health issues. This trend is propelling the demand for dialysis treatments. Advancements in dialysis technology are also contributing to market expansion. Ongoing innovations, such as more efficient dialyzers, improved access devices, and enhanced monitoring systems, are enhancing the effectiveness and safety of both hemodialysis and peritoneal dialysis. Furthermore, the shift toward home-based peritoneal dialysis is gaining momentum, driven by technological improvements, comprehensive training programs, and patient education. Patients are increasingly opting for the convenience and flexibility offered by home-based care. Aging populations, greater healthcare expenditure, improved health insurance coverage, and a focus on patient-centered care are further propelling the demand for dialysis services. Additionally, the integration of digital health technologies, telehealth, and innovations in dialysis solutions are shaping the future of renal replacement therapies. These factors collectively underscore the vital role played by the Hemodialysis and peritoneal dialysis market in improving the quality of life for individuals with ESRD.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of hemodialysis & peritoneal dialysis. The growth and trends of hemodialysis & peritoneal dialysis industry provide a holistic approach to this study.
Market Segmentation
This section of the hemodialysis & peritoneal dialysis market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Type
- Hemodialysis (Conventional Hemodialysis, Short Daily Hemodialysis, Nocturnal Hemodialysis)
- Peritoneal Dialysis (Continuous Ambulatory Peritoneal Dialysis (CAPD), Automated Peritoneal Dialysis (APD))
By Product
- Device (Machine, Dialyzer, Water Treatment System, Others)
- Consumables (Bloodline, Concentrates, Catheters, Others)
By End-Use
- Home-Based
- Hospital-Based
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Hemodialysis & Peritoneal Dialysis market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Hemodialysis & Peritoneal Dialysis Market Share by Region (Representative Graph)

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Hemodialysis & Peritoneal Dialysis market include Baxter, B. Braun Melsungen AG, Fresenius Medical Care AG, Medtronic, Asahi Kasei Medical Co., Ltd., Nipro Corp., DaVita, BD, Nikkiso Co., Ltd., Cantel Medical. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.